Literature DB >> 7963693

Immunopathogenesis of toxoplasmic encephalitis.

C A Hunter1, J S Remington.   

Abstract

The incidence of toxoplasmic encephalitis (TE) has increased with the increasing numbers of patients with immunodeficiencies, in whom reactivation of latent Toxoplasma infection may occur. This highlights the important role of the immune response in maintaining infection with Toxoplasma gondii in a latent form. Because the brain is the most commonly affected site of latent infection and because it is anatomically unique in regard to the immune system, understanding the systemic immune response to infection within the brain is important. Murine models have proven useful for the study of the immune response to T. gondii and identified the importance of cytokines and NK and T cells in the regulation of protective immunity to T. gondii. Further studies on the development of TE have indicated the possible importance of the interactions of glial cells, such as microglia and astrocytes, with infiltrating T cells to mediate immunity to T. gondii within the brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963693     DOI: 10.1093/infdis/170.5.1057

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Rapid identification of virulent type I strains of the protozoan pathogen Toxoplasma gondii by PCR-restriction fragment length polymorphism analysis at the B1 gene.

Authors:  M E Grigg; J C Boothroyd
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

2.  p47 GTPases regulate Toxoplasma gondii survival in activated macrophages.

Authors:  Barbara A Butcher; Robert I Greene; Stanley C Henry; Kimberly L Annecharico; J Brice Weinberg; Eric Y Denkers; Alan Sher; Gregory A Taylor
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design.

Authors:  Matthew E Welsch; Jian Zhou; Yueqiang Gao; Yunqing Yan; Gene Porter; Gautam Agnihotri; Yingjie Li; Henry Lu; Zhongguo Chen; Stephen B Thomas
Journal:  ACS Med Chem Lett       Date:  2016-09-17       Impact factor: 4.345

4.  IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii.

Authors:  Jonathan S Silver; Jason S Stumhofer; Sara Passos; Matthias Ernst; Christopher A Hunter
Journal:  J Immunol       Date:  2011-05-23       Impact factor: 5.422

Review 5.  Advances in imaging the innate and adaptive immune response to Toxoplasma gondii.

Authors:  Beena John; Wolfgang Weninger; Christopher A Hunter
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

6.  Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis.

Authors:  D K Howe; S Honoré; F Derouin; L D Sibley
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

7.  Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP.

Authors:  S K Halonen; G A Taylor; L M Weiss
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

8.  Occipital condylar avulsion fractures in the acute trauma setting: Stable or unstable injury?

Authors:  Peter Fiester; Dinesh Rao; Erik Soule; Gazanfar Rahmathulla
Journal:  Eur Spine J       Date:  2021-08-02       Impact factor: 3.134

9.  Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis.

Authors:  E G Lago; G S Conrado; C S Piccoli; R L Carvalho; A L Bender
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

10.  Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death.

Authors:  Yang O Zhao; Aliaksandr Khaminets; Julia P Hunn; Jonathan C Howard
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.